Conditions AND treats
LFs therapeutic effects include mitigating CECs damage and promoting cellular repair, as demonstrated in animal models of DED (Pattamatta et al., 2013
Composition GHK-Cu: 50 mg KPV: 10 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of four co-formulated peptides Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
You may also experience fatigue, nausea, diarrhea, joint pain, or water retention
Sharon Rated 5 out of 5 Brandalyn Gates Rated 5 out of 5 Lorena Valle Rated 5 out of 5 Sharon Rated 5 out of 5 kendrea Rated 5 out of 5 Shelby Garrard Rated 5 out of 5 Connie M
Epub 2019 May 31
